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Abstract
Objectives: In developing countries, bacteriuria is asso-
ciated with significant maternal and foetal risks. Rapid
emergence of antibiotic resistance warrants continuous
monitoring of the susceptibility patterns of bacterial
isolates. In this study, we report our findings regarding
the drug resistance patterns of bacteria isolates from
pregnant women with urinary tract infections (UTI).
Methods: This study included 1358 pregnant women
attending the antenatal clinic at the Department of Ob-
stetrics and Gynecology between July 2013 and August
2014. Urine specimens were processed for isolation and
identification of bacterial species following standard
microbiological methods. The disc diffusion test was used
to determine the antimicrobial resistance patterns of the
recovered isolates at the Central Laboratory of Micro-
biology of Nepalgunj Medical College, Nepal.
Results: Three hundred and seventeen isolates were posi-
tive for significant bacteriuria. E. coli, K. pneumonia,
P. aeruginosa, E. faecalis, S. aureus, P. mirabilis,
CoNS, and P. vulgaris accounted for 61.5%, 17%, 7.5%,
5.3%, 2.8%, 2.5%, 1.8%, and 1.2% of bacterial isolates,y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2015.01.011
S. Khan et al. 341respectively. Resistance to erythromycin (58.6%),
co-trimoxazole (57.4%) and ciprofloxacin (50.1%) was
observed. Among the 317 positive isolates, 203 (64%)were
fromwomen in the 21e30-year-old age group, and the rate
of bacteriuria in this group was statistically significantly
more than those for the other age groups (P < 0.05).
Conclusions: Bacteriuria is frequent among pregnant
women, which generates a need for routine urine culture
screening. In this study, E. coli was the most predominant
bacterial species identified followed by K. pneumonia.
Furthermore, women in the 21e30-year-old group were
at a higher risk of UTI. Erythromycin, co-trimoxazole
and ciprofloxacin should not be empirically used as
first-line drugs in the treatment of UTIs. Continuous local
monitoring of resistance patterns is necessary to deter-
mine the appropriate empirical antimicrobial therapy.
Keywords: Bacteriuria; Drug resistance; Pregnant women;
Urinary tract infection
 2015 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Bacteriuria is the presence of bacteria in the urine. Bacte-
riuria is said to be significant in the presence of 105 colony
forming units (CFU)/mL. One issue with bacteriuria is that it
does not always present with symptoms.1 Occult infection
occurs in approximately 2e7 % of pregnancies, and 30e40
% of cases develop acute pyelonephritis later into their
pregnancy.2 Additionally, there are associations between
maternal pregnancy complications and pyelonephritis,
including hypertension, preeclampsia, anaemia, amnionitis,
and endometritis.3 Pyelonephritis can lead to renal scarring,
hypertension and renal failure in the long term.4 In
pregnancy, pyelonephritis increases the risk of preterm
labour and delivery, which results in premature delivery and
low birth weight (LBW) with high perinatal morbidity and
mortality.2 Another study showed that asymptomatic
bacteriuria (ASB) is independently associated with preterm
delivery, hypertensive disorders, recurrent abortions,
intrauterine growth restriction (IUGR), polyhydramnios
and oligohydramnios, premature rupturing of membranes,
and labour induction.5 Additionally, ASB increases the
risk of developing pyelonephritis in the puerperium.6
The most commonly reported etiologic agent of bacteriuria
is Escherichia coli (E. coli) (80e90 %), followed by
Proteus mirabilis (P. mirabilis), Klebsiella pneumonia (K.
pneumonia) and Pseudomonas aeruginosa (P. aeruginosa).7
Gram-positive organisms, including B streptococci, Entero-
coccus faecalis (E. faecalis) and coagulase-negative staphy-
lococci (CoNS), are less commonly recognised as etiologic
agents of bacteriuria.8 Urinary tract infection (UTI) cases
have shown increasing antimicrobial drug resistance in
recent years.9 Accurate bacteriologic records of cultureresults may help guide the determination of empirical
therapies before sensitivity patterns are available. This
study was performed to determine the common bacteria
that cause UTIs in pregnant women and the antibiotic
susceptibility pattern of these uropathogens. The
prevalences and resistance patterns of pathogens causing
UTI and the risk factors associated with the identified
pathogens are reported in this study. The results of this
study could be important for the planning and development
of appropriate strategies to control and prevent UTIs in
pregnant women.Materials and Methods
This study included 1358 pregnant women who attended
the antenatal clinic at the department of Obstetrics and
Gynaecology between July 2013 and August 2014. Speci-
mens were processed at the Central Laboratory of Micro-
biology of Nepalgunj Medical College, Nepal. The samples
were collected from asymptomatic pregnant females with a
gestation period of 28 weeks or less. Prior to sample
collection, socio-demographic and clinical data were
collected by face-to-face administration of structured
questionnaires. Pregnant women with a history of UTI
symptoms (e.g., dysuria, frequency and urgency, etc),
pregnancy induced diabetes mellitus/hypertension, a his-
tory of antibiotic therapy taken within two weeks prior to
the study, pyrexia of unknown origin and known congenital
anomalies of the urinary tract were excluded from this
study. Ethical clearance from the Ethics Committee of
Nepalgunj Medical College, Nepalgunj was obtained before
commencing the study. Informed consent was obtained
from all patients. Participants were advised to collect a
clean catch of 10e20 ml of midstream urine (MSU) using
sterile disposable leak proof containers and using aseptic
collection techniques.Culturing of specimens
Aliquots of urine samples were centrifuged at 500 G for
five minutes. The sediment from the sample was streaked
onto culture media using a sterile standard nichrome loop of
28 SWG with an internal diameter 3.26 mm and a volume
holding capacity of 0.004 ml. The samples were cultured on
blood agar (BA), mannitol salt agar (MSA) and Mac-
Conkey agar (MA) plates. Then, the plates were incubated
aerobically at 37 C for 24 h.10Identification of isolated organisms
Colony-forming units (CFUs) were estimated, and bac-
terial isolates with growth of  105 CFU/mL of urine (i.e.,
400 colonies or more) were considered to indicate significant
bacteriuria. The organisms were identified following stan-
dard procedures.10 Colonies on plates with significant
growth were classified as Gram-positive or Gram-negative.
The genera and species of bacteria were identified using the
Analytic Profile Index (API) 20E system (BioMe´ rieux, 69280
Marcy-l’Etoile, France).
Table 1: Result of culture.
Result of culture Number of cases Percentage (%)
Significant bacteriuria 317 23.34
Insignificant bacteriuria 106 7.80
Contamination 184 13.54
Sterile 751 55.30
Total 1358 100
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The standardised KirbyeBauer disc diffusion test of the
Clinical And Laboratory Standards Institute (formerly
NCCLS) was used for antibiotic susceptibility testing on
Mueller-Hinton agar, and the results were interpreted
accordingly.11 The antibiotics tested included ampicillin
(10 mg), amikacin (30 mg), cefepime (50 mg), ceftriaxone
(30 mg), ciprofloxacin (5 mg), nitrofurantoin (300 mg), co-
trimoxazole (25 mg), cefuroxime (30 mg), erythromycin
(15 mg), and imipenem (10 mg). All drugs and media were
manufactured by Hi-Media Lab. Pvt Ltd, Mumbai, India.Statistical analysis
The data obtained were analysed using the Statistical
Package for Social Sciences (SPSS) software (version 16,
SPSS, Inc, Chicago, IL, USA). Associations between age-
groups and prevalences of different bacterial species were
assessed using the chi-square test. P values of <0.05 were
considered to indicate statistically significant differences.Results
A total of 1358 urine samples were screened, and 317 of
them (23.34%) were positive for significant bacteriuria
(CFU  105/mL) (Table 1). Bacterial species were isolated
from patients that were 20e50 years of age. A high
prevalence of bacteriuria (64.04%) was identified in the
21e30 year-old age group, and the prevalence in this age
group was statistically significantly higher than those of
other age groups (P < 0.05). The following bacterial species
were identified: E. coli, 195 isolates (61.51%); K. pneumonia,
54 isolates (17.03%); P. aeruginosa, 24 isolates (7.57%);Table 2: Distribution of bacterial isolates recovered from different a
Name of isolate Age groups (years) distribution
<20
No.(%)
21e30
No.(%)
E. coli 15 129
K. pneumonia 3 39
P. aeruginosa 6 11
E. faecalis 3 9
S. aureus 2 6
P. mirabilis 2 4
CoNS 3 2
P. vulgaris 1 3
Total No.(%) 35 (11.04) 203 (64.04)E. faecalis, 17 isolates (5.36%); S. aureus, 9 isolates (2.84%);
P. mirabilis, 8 isolates (2.52%); CoNS, 6 isolates (1.89%);
and P. vulgaris, 4 isolates (1.26%) (Table 2). E. coli was the
predominant isolate of the samples examined in this study.
The resistance pattern of bacterial species isolated from
UTIs from July 2013 to August 2014 is shown in Table 3.
Over 50% of bacterial isolates were resistant to two or
more antibiotics, including erythromycin, ciprofloxacin and
co-trimoxazole. All isolates from the 41e50-year-old age
group were resistant to all 3 of those drugs. The maximum
resistant isolates were observed in 21e30 and 31e40-year-
old age groups. No resistance to imipenem was observed in
the samples examined in this study.Discussion
Asymptomatic bacteriuria (ASB) in pregnant women is
an important causative factor of premature birth, low birth
weight, postpartum UTIs and higher foetal mortality rates.
Women with bacteriuria have a 20e50-fold increased risk of
developing pyelonephritis compared to women who do not
have bacteriuria.12 Women who have positive urine cultures
should be treated based on the antimicrobial sensitivity
patterns of the bacteria isolated from their samples to
prevent maternal and foetal morbidities. In this study, the
prevalence of asymptomatic bacteriuria was 23.34%, which
was similar to that observed by a study in Chitwan, Nepal
conducted by Neupane et al., (26%) and that observed by
a study in Cameroon conducted by Mokube M.N. et al.
(23.5%).13,14 In contrast, some studies found lower
prevalences than our study,12,15e17 and a study by Imade
et al., (45.3%) reported a higher prevalence than our
study.1 These varying results may have been due to
differences in the areas being studied, in the social habits of
the communities being studied and in the socio-economic
statuses, standards of personal hygiene and education
levels of the patients being studied. The current study that the
21e30-year-old age group had the highest prevalence of
infection (64.04%), followed by the 31e40-year-old age
group (22.71%), and these results were similar to those of a
study conducted in India by Sujatha R. et al.17 Alghalibi
et al.,18 reported a higher prevalence of UTIs in pregnant
women who were 21e25 years of age and Turpin et al.,15
reported a higher prevalence of ASB in pregnant women
who were 35e39 years of age. Advanced maternal age (ofge groups.
Total
No.(%)
31e40
No.(%)
41e50
No.(%)
49 2 195 (61.51)
12 0 54 (17.03)
6 1 24 (7.57)
3 2 17 (5.36)
1 0 9 (2.84)
1 1 8 (2.52)
0 1 6 (1.89)
0 0 4 (1.26)
72 (22.71) 7 (2.29) 317 (100)
Table 3: Resistance of the bacterial isolates to a panel of ten antibiotics.
Name of isolates Antimicrobial agent
AMP
%
(No)
COT
%
(No)
AK
%
(No)
NIT
%
(No)
E
%
(No)
CIP
%
(No)
CTR
%
(No)
CXM
%
(No)
CPM
%
(No)
IPM
%
(No)
E. coli
(N ¼ 203)
31.03
(63)
56.16
(114)
19.21
(39)
15.27
(31)
68.97
(140)
61.08
(124)
10.84
(22)
11.82
(24)
00
e
0
e
K. pneumonia
(N ¼ 54)
44.44
(24)
51.85
(28)
00
e
12.96
(7)
29.63
(16)
22.22
(12)
7.41
(4)
11.11
(6)
3.70
(2)
0
e
P. aeruginosa
(N ¼ 24)
100
(24)
54.17
(13)
20.83
(5)
75
(18)
70.83
(17)
29.16
(7)
66.66
(16)
29.16
(7)
58.33
(14)
0
e
E. faecalis
(N ¼ 17)
58.82
(10)
52.94
(9)
11.76
(2)
35.29
(6)
29.41
(5)
17.65
(3)
00
e
5.88
(1)
00
e
0
ee
S. aureus
(N ¼ 9)
55.56
(5)
77.78
(7)
33.33
(3)
00
e
44.44
(4)
00
e
22.22
(2)
33.33
(3)
11.11
(1)
0
e
P. mirabilis
(N ¼ 8)
12.5
(1)
50
(4)
00
e
50
(4)
25
(2)
87.5
(7)
00
e
12.5
(1)
0
e
0
e
CoNS
(N ¼ 6)
16.67
(1)
83.33
(5)
50
(3)
00
e
33.33
(2)
50
(3)
16.67
(1)
00
e
0
e
0
-
P. vulgaris
(N ¼ 4)
00
e
50
(2)
00
e
50
(2)
00
e
75
(3)
00
e
0
e
0
e
0
e
Total
(N ¼ 317) % (No)
40.38
(128)
57.42
(182)
16.40
(52)
21.45
(68)
58.68
(186)
50.16
(159)
14.20
(45)
13.25
(42)
5.36
(17)
00
(00)
Abbreviations: AMP¼Ampicillin, AK¼Amikacin, CPM¼ Cefepime, CTR¼ Ceftriaxone, CIP¼ Ciprofloxacin, NIT¼Nitrofurantoin,
COT ¼ Co-trimoxazole, CXM ¼ Cefuroxime, E ¼ Erythromycin, IPM ¼ Imipenem.
S. Khan et al. 34335years) was reported as a risk factor for asymptomatic
bacteriuria.19 The observed trend of bacteriuria in pregnant
women in this study and other studies showed that the 21e
40 year-old age group is a high risk group for the develop-
ment of UTIs during pregnancy. The bacteria which are
responsible for asymptomatic bacteriuria are of faecal origin
and colonise the periurethral area. The predominant bacte-
rial isolates observed in this study were E. coli (61.51%),
followed by K. pneumonia (17.03%) and P. aeruginosa
(7.57%). The predominance of E. coli was reported previ-
ously by Chandel et al.,16 Imade et al.,1 and Sujatha R. et
al.,.17 K. pneumonia was found to be the second most
prevalent pathogen in this study, and this result is in
agreement with those of studies recently conducted in the
Sudan, Ethiopia, India, Cameroon and Nigeria.1,14,20e22
However, Muharram S. H. et al reported a higher
incidence of K. pneumonia than was observed in this study.23
The third most prevalent pathogen in this study was
P. aeruginosa (7.57%), and this result is consistent with those
of recent studies conducted in Cameroon, Nigeria and In-
dia.1,14,22 Additionally, P. aeruginosa is the epitome of an
opportunistic pathogen of humans and is notorious as an
etiologic agent of nosocomial infections. In this study, there
was a considerable prevalence (5.36%) of E. faecalis, which
was probably due to pregnancy and contamination.
Naturally, the urethra is closer to the anus in females than
in males24; moreover, in pregnant women, the distension of
the abdomen makes anal cleaning more cumbersome. The
other organisms isolated during this study included those of
S. aureus, CoNS, and Proteus species, and these species less
commonly cause UTIs than others.6 Antimicrobial
sensitivities and resistance patterns vary from community to
community and from hospital to hospital due to the
emergence of resistant strains caused by the indiscriminate
use of antibiotics. In this study, the isolates showed 100%sensitivity to imipenem. Most of the uropathogens isolated
in our study were most susceptible to cephalosporins, such
as cefepime, ceftriaxone, and cefuroxime. Isolates identified
by Njunda et al.25 also showed a high sensitivity to
cephalosporin. This finding is unlike those of other studies
that found that isolates had greater sensitivities to
fluoroquinolones, such as ciprofloxacin.1,26 It is worth
noting that the administration of cephalosporins is
relatively safer than the administration of fluoroquinolones
during pregnancy; thus, fluoroquinolone treatment during
pregnancy is contraindicated, unless no other treatment
alternatives are available.27 In our study, the bacterial
isolates showed greater sensitivities to nitrofurantoin than
to fluoroquinolones. Okonko et al. also found that bacterial
isolates had high sensitivities to nitrofurantoin,28 but the
findings of Mokube M. N. et al. regarding nitrofurantoin
sensitivity differed from those of our study.14 The isolates in
our study showed the lowest sensitivities to cotrimoxazole
and erythromycin, which is in agreement with the findings
of Akoachere et al.14,17 The resistance to cotrimoxazole and
erythromycin in our study can be explained by their
widespread over-the-counter use in the location of our
study. In mid-western and far-western Nepal, isolates
exhibited considerable susceptibility to antibiotics used for
the empirical treatment of UTI in pregnancy, such as ampi-
cillin and amikacin. The considerable susceptibility to ami-
kacin observed in that study correlates with findings of
Mokube M. N. et al. and Lone T.A et al.14,22 In a study
conducted by G Nath et al., a significantly higher rate of
LBW babies was observed in women with UTIs (22.4%)
than in women without UTIs (7.7%).29 The incidence of
premature birth and LBW babies may be greater in patients
with untreated UTIs. Furthermore, according to a study by
the World Health Organization (WHO) on the global
burden of disease, LBW and perinatal causes of LBW are
Pregnancy-associated ASB and drug resistance344the leading causes of death and disability in newborns. To
counter the high rates and disproportionate world burden
of neonatal morbidity and mortality, the WHO developed
the MOTHER BABY PACKAGE as a universal
instrument for the safe motherhood initiative.30 This
initiative may drastically reduce the financial burden caused
by pregnancy complications, as screening and treatment for
asymptomatic bacteriuria costs approximately US $5.00e
6.00, while managing complications, such as pre-term birth
and IUGR, costs approximately US $60e70 per case in
Nepal.31 Therefore, it is beneficial to screen and treat
pregnant females with asymptomatic bacteriuria to avoid
complications linked to this disease.Conclusions
Pregnancy associated bacteriuria is a common entity. The
common pathogens responsible for bacteriuria are of faecal
origin, and the most common uropathogen that has been
isolated from pregnant women by this and other studies is
E. coli. The pattern of antibiotic resistance varied according
to bacterial species, and multi-resistant isolates were
observed. For all antenatal women, routine urine cultures
and antibiotic sensitivity tests should be performed to detect
asymptomatic bacteriuria and determine the resistance pat-
terns of isolated uropathogens. It is necessary to stop the
culture of antimicrobial abuse, and continuous surveillance
of multidrug resistant strains is highly important to follow
changes in antibiotic susceptibility patterns over time.Conflict of interest statement
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